adplus-dvertising
Connect with us

Business

Canada begins review of Oxford coronavirus vaccine candidate – Global News

Published

 on


OTTAWA – Canada launched on Friday a real-time review of data from AstraZeneca and Oxford University’s potential COVID-19 vaccine, becoming the latest country to speed up its approval process.

Read more:
Canada signs deal to obtain 20M doses of Oxford coronavirus vaccine candidate

As the battle against the coronavirus pandemic intensifies, with infections and deaths still rising, Canada‘s health ministry said it had received its first submission for authorisation for the vaccine on Thursday.

The aim of a rolling review is to accelerate the process and last month, Canada‘s health minister Patty Hajdu signed an order allowing companies developing vaccines to submit safety and efficacy data and information as they become available.






1:40
Canada signs new coronavirus vaccine deals


Canada signs new coronavirus vaccine deals

Story continues below advertisement

The European Union’s health regulator on Thursday also started a rolling review of the first batch of data for the potential vaccine being worked on by AstraZeneca.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The British drugmaker and Oxford University did not immediately respond to requests for comment.

Read more:
Should the COVID-19 vaccine be mandatory? New poll suggests Canadians are divided

The Canadian ministry will not decide whether to authorize this or any other vaccine until it has received the necessary evidence to support its safety, efficacy and quality, it said

It is also in talks with several vaccine manufacturers and said any company can apply to use the rolling review process.

Last week, Canada agreed to buy up to 20 million doses of the vaccine candidate, one of several deals it has signed to secure around 300 million potential shots as the global death toll from coronavirus exceeds 1 million.


Click to play video 'Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness'



1:46
Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness


Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness

Called AZD1222 or ChAdOx1 nCoV-19, the AstraZeneca vaccine is seen as leading the race to inoculate people against COVID-19. Other vaccine hopefuls in advanced stages include those from Pfizer, Moderna and Sinovac.

Story continues below advertisement

— Reporting by Steve Scherer in Ottawa; additional reporting by Pushkala Aripaka in Bengaluru and Alistair Smout in London; Writing by Josephine Mason in London Editing by Chizu Nomiyama, Mark Potter and Alexander Smith

© 2020 Thomson Reuters

Let’s block ads! (Why?)

728x90x4

Source link

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending